FDA Clears HemoSonics Quantra QPlus System a Rapid Coagulation Diagnostic for Hospital Transfusion Management

FDA Clears HemoSonics’ Quantra QPlus System, a Rapid Coagulation Diagnostic for Hospital Transfusion Management

10:56 EDT 12 Apr 2019 | Speciality Pharma Journal

Charlottesville, VA – March 13, 2019 – HemoSonics today announced that its innovative Quantra Hemostasis Analyzer platform, and its initial QPlus cartridge have been granted de novo marketing authorization by the FDA and are now available for sale in the United States. The fast and easy-to-use Quantra QPlus System provides novel and actionable information on coagulation status …

More From BioPortfolio on "FDA Clears HemoSonics’ Quantra QPlus System, a Rapid Coagulation Diagnostic for Hospital Transfusion Management"